BioTek Instruments, Inc., continues their global expansion in the microplate-based technology market with the establishment of BioTek Japan.
Managed by Mr. Satoshi Sagara, the new direct sales and service organization in Tokyo will focus on growing BioTek's brand and expanding the sales network in Japan.
Long-time partner and distributor, DS Pharma Biomedical Co., Ltd., will work closely with BioTek Japan to ensure a seamless transition.
BioTek Japan will continue to work with existing distributor, Central Scientific Comm., Inc., to grow the Japanese business.
"The establishment of BioTek Japan will allow BioTek to increase our presence in this very important marketplace," commented Briar Alpert, BioTek President and CEO.
Alpert continued, "In addition to providing local service and application support, our customers in Japan will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced customer satisfaction for our Japanese customers."